Salmon, Jane
Wallace, Daniel J https://orcid.org/0000-0002-2502-1372
Rus, Violeta
Cox, Addison
Dykas, Claire
Williams, Brooke
Ding, Yunpeng
Hals, Petter-Arnt
Johnsen, Line
Lipsky, Peter E https://orcid.org/0000-0002-9287-1676
Clinical trials referenced in this document:
Documents that mention this clinical trial
Validation of eight endotypes of lupus based on whole-blood RNA profiles
https://doi.org/10.1136/lupus-2025-001526
AB0536 CORRECTION OF OMEGA-3 FATTY ACID DEFICIENCY AND IMPROVEMENT IN DISEASE ACTIVITY IN SLE PATIENTS TREATED WITH A CONCENTRATED EXTRACT OF KRILL OIL (AKM-3031)
https://doi.org/10.1136/annrheumdis-2023-eular.4698
1104 Machine learning to determine the endotype of SLE patients: a validation study
https://doi.org/10.1136/lupus-2023-lupus21century.84
Correction of omega-3 fatty acid deficiency and improvement in disease activity in patients with systemic lupus erythematosus treated with krill oil concentrate: a multicentre, randomised, double-blind, placebo-controlled trial
https://doi.org/10.1136/lupus-2024-001201
Documents that mention this clinical trial
Validation of eight endotypes of lupus based on whole-blood RNA profiles
https://doi.org/10.1136/lupus-2025-001526
AB0536 CORRECTION OF OMEGA-3 FATTY ACID DEFICIENCY AND IMPROVEMENT IN DISEASE ACTIVITY IN SLE PATIENTS TREATED WITH A CONCENTRATED EXTRACT OF KRILL OIL (AKM-3031)
https://doi.org/10.1136/annrheumdis-2023-eular.4698
1104 Machine learning to determine the endotype of SLE patients: a validation study
https://doi.org/10.1136/lupus-2023-lupus21century.84
Correction of omega-3 fatty acid deficiency and improvement in disease activity in patients with systemic lupus erythematosus treated with krill oil concentrate: a multicentre, randomised, double-blind, placebo-controlled trial
https://doi.org/10.1136/lupus-2024-001201
Funding for this research was provided by:
Aker BioMarine Human Ingredients AS